drugset
drugset / Trial / NCT07652606

Expanded Access to RGX-202

NCT07652606 ↗

Expanded access Temporarily not available REGENXBIO Inc.

Summary

Provide single patient expanded access to RGX-202 for eligible patients

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Ompenaclid Small molecule — —

Indications

No indication recorded.